CONCLUSION: The obtained results indicate the possibility of creating, along with buccal, in-halation, transdermal and ocular preparations, intranasal non-invasive drugs that provide more effective therapy for psychiatric and neurodegenerative diseases, such as schizophrenia, depression, anxiety, ADHD, Alzheimer disease and Parkinson disease.